Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small platform update to the study details page.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new revision entry 'Revision: v3.6.5' has been added. The 'Investigator Inquiry Form' and the previous 'Revision: v3.6.4' entry have been removed, reflecting administrative updates to the study record rather than changes to trial content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4 to reflect a small backend/template update.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision tag v3.6.3 is now shown, replacing v3.6.2, signaling a minor update to the page's revision history without substantive changes to the study information.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, reflecting a newer build of the page.SummaryDifference0.0%

- Check90 days agoChange DetectedDeleted the Bristol-Myers Squibb clinical trial educational resource from the Study Details page, removing access to the trial's educational materials.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.